ArticleInternational journal of endocrinology2026
Association Between Uric Acid-to-HDL Cholesterol Ratio and Sarcopenia: Sex-Specific Patterns From NHANES 2011-2018.
Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Sarcopenia, characterized by progressive skeletal muscle mass and strength loss, significantly impacts elderly health. The uric acid-to-high-density lipoprotein cholesterol Ratio (UHR), an emerging metabolic-inflammatory marker, may be associated with sarcopenia, but large-scale studies are lacking. Methods: We conducted a cross-sectional analysis using NHANES 2011-2018 data (weighted Results: After multivariable adjustment, UHR showed significant positive association with sarcopenia (OR = 1.060, 95% CI: 1.041-1.080, Conclusion: Elevated UHR significantly associates with sarcopenia with pronounced gender differences and may represent a promising, cost-effective biomarker for improved early detection in aging populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.